CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 89 filers reported holding CTI BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $44,000 | +300.0% | 108,011 | +261.0% | 0.00% | – |
| Q3 2016 | $11,000 | -76.6% | 29,916 | -78.1% | 0.00% | -100.0% |
| Q2 2016 | $47,000 | -50.0% | 136,911 | +78.4% | 0.00% | -50.0% |
| Q4 2015 | $94,000 | -39.4% | 76,725 | -27.5% | 0.00% | -33.3% |
| Q3 2015 | $155,000 | -76.4% | 105,826 | -68.5% | 0.00% | -75.0% |
| Q2 2015 | $656,000 | +358.7% | 335,493 | +336.8% | 0.01% | +300.0% |
| Q1 2015 | $143,000 | -39.1% | 76,799 | -23.6% | 0.00% | -25.0% |
| Q4 2014 | $235,000 | 0.0% | 100,546 | +3.6% | 0.00% | -20.0% |
| Q3 2014 | $235,000 | +45.1% | 97,097 | +68.3% | 0.01% | +66.7% |
| Q2 2014 | $162,000 | – | 57,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|